Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Zosano Pharma Corp (ZSAN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Service revenue  0.80.2    0.32.9
            Service revenue growth  250.4%    -100.0%-89.1%-32.7%
Operating expenses:          
Cost of service revenue  0.80.2      
Research and development  21.021.625.425.520.120.520.411.0
General and administrative  10.511.211.89.48.28.26.34.4
Impairment loss     0.50.1   
    Total operating expenses  32.333.037.2     
    Loss from operations  -31.5-32.8-37.2-35.4-28.4-28.6-26.4-12.6
            Operating margin  -4016.8%-14624.1%    -8424.3%-440.8%
   
Other income (expense):          
Interest income  0.00.00.20.40.1   
Interest expense  -0.2-0.7-0.5-0.4-0.8-1.2-1.6-1.8
Other income (expense), net  1.80.1-0.10.00.00.0-0.1-0.1
    Loss before provision for income taxes  -29.9-33.4-37.6-35.4-29.1-29.8  
    Net loss  -29.9-33.4-37.6-35.4-29.1-29.8-28.4-14.2
   
Net loss per common share - basic (in USD per share)  ($0.27)($0.49)($2.29)($3.74)($16.82)($43.36)($2.49)($2.78)
Net loss per common share - diluted (in USD per share)  ($0.27)($0.49)($2.29)($3.74)($16.82)($43.36)($2.49)($2.78)
   
Weighted-average common shares used in computing net loss per common share – basic  112.167.916.49.51.70.711.45.1
Weighted-average common shares used in computing net loss per common share – diluted  112.167.916.49.51.70.711.45.1
   
Revenue from Contract with Customer, Product and Service [Extensible List]          
Cost, Product and Service [Extensible List]          

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy